Article Details
Retrieved on: 2019-02-16 02:19:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Boothbay Fund Management Llc increased its stake in Biocryst Pharmaceuticals (BCRX) by 421.89% based on its latest 2018Q3 regulatory filing with ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here